Company Search:
Advanced Search
Sponsored Links
Realsource Residential Inc Company Snapshot
Realsource Residential Inc operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Realsource Residential Inc with three other pharmaceutical manufacturers in North America: Respirerx Pharmaceuticals Inc (2015 sales of $86,916.00 ), CytRx Corporation ($100,000.00 of which 100% was Pharmaceutical Product Developers), and Boston Therapeutics Inc ($98,941.00 of which 100% was Sugardown TM).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Realsource Residential Inc
  Stock Performance Chart for Realsource Residential Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): .10
(Figures in U.S. Dollars)
1 Week 12.7%   13 Weeks 147.8%  
4 Weeks n/a   52 Weeks -15.0%  
Realsource Residential Inc Key Data:
  Ticker: RSRT Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2015 Sales 93,114
(Year Ending Jan 2016).
Employees: 1
  Currency: U.S. Dollars Market Cap: 1,577,309
  Fiscal Yr Ends: December Shares Outstanding: 15,719,645
  Share Type: Common Closely Held Shares: 9,851,368
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.